MKI67 and breast cancer: A large number of BC criteria are routinely and widely acknowledged in the clinical field, including estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (Her2), Ki67 proliferative index, TNM stage, tumor grade, metastatic status and molecular classification have been suggested for prognosis [7].